Clinic Software← All companies
StageSeries A - II
Raised$180M
Founded2020
Employees4
LocationDallas, TX
Business modelB2B
Valuation$1.8 billion
About
We enable Molecular Diagnosis in the clinical laboratory. We establish a new lab or upgrade your testing capabilities. Contact Us for: PCR Synndromic panel testing: UTI, STI, Wound-Nail, Respiratory and COVID-Flu NGS Testing: Precision Metagenomics. Oncology, Preventive Genomics
Product
- Value proposition
- Specialized laboratory consulting to establish and optimize molecular diagnostics, CLIA-compliant labs, and NGS-based testing across hospital, clinic, and reference lab settings.
- Target customers
- Biotech startups, diagnostic and medical device developers, clinical laboratories seeking to establish or expand molecular diagnostic capabilities
Founders
- Joe Betts-Lacroix — Co-Founder and CEO
- Sheng Ding — Co-Founder
- Matt Buckley — Co-Founder
Categories
Laboratory consultingMolecular diagnosticsClinical laboratory support
Products
Molecular diagnostic laboratory setupQuality management systemsPre-inspection and mock inspection servicesAccreditation supportInstrumentation and test-menu optimizationOperational and financial consultingHiring and training for labsFacility optimizationExpansion of molecular diagnosis offering
Key features
CLIA lab establishment and validationMock inspections with detailed reportsQuality management system implementationAccreditation support (CAP/CLIA)Facility and instrument optimizationTest menu development and expansionFinancial analysis for labsOperational support and pre-inspection preparationsHiring and training for lab staff
Technologies
NGSPCR/Molecular diagnosticsQuality Management SystemsLaboratory instrumentation
Care settings
hospitalclinicreference laboratorieslab startup environments
Certifications
CAP accreditation supportCLIA lab support
Investors
4P CapitalTeam Ignite VenturesSam AltmanSandro SalsanoProsto VC
News
- Retro Biosciences, backed by Sam Altman, is raising $1 billion to extend human lifespan | TechCrunch · 2025-01-24T23:24:26.000Z
- Accelerating life sciences research | OpenAI · 2025-08-22T00:00:00.000Z
- Altman-Backed Regenerative Medicine Startup, Retro Biosciences, Closes Funding Round at $1.8B Valuation - Regen Report · 2026-05-23T22:39:14.000Z
- Joe Betts-Lacroix on Retro Bio and Its Recent AI Advancement · 2025-10-02T16:00:05.000Z
